Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection

Innes, Hamish; Jepsen, Peter; McDonald, Scott; Dillon, John; Hamill, Victoria; Yeung, Alan; Benselin, Jennifer; Went, April; Fraser, Andrew; Bathgate, Andrew; Ansari, M. Azim; Barclay, Stephen T.; Goldberg, David; Hayes, Peter C.; Johnson, Philip; Barnes, Eleanor; Irving, William; Hutchinson, Sharon; Guha, Indra Neil

doi:10.1016/j.jhepr.2021.100384

All Outputs (2)

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study (2023)
Journal Article

Objectives To quantify mortality rates for patients successfully treated for hepatitis C in the era of interferon-free, direct acting antivirals and compare these rates with those of the general population. Design Population based cohort study.... Read More about Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.

Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection (2021)
Journal Article

Background & Aims: Hepatocellular carcinoma (HCC) prediction models can inform clinical decisions about HCC screening provided their predictions are robust. We conducted an external validation of 6 HCC prediction models for UK patients with cirrhosis... Read More about Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection.